Delivery Order SPE2DB20D3103-SPE2DB24FP1D9
- Not listed
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies globally. The contract, valued at $8,276.19, is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order without a set-aside designation, issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Medical Supply Chain division of the Defense Logistics Agency (DLA). The $9,272.10 delivery order contract is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml medication. The contract has an ultimate completion date of October 22, 2024 and is a firm fixed price arrangement. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,853.27, is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to support federal healthcare programs. The contract has an ultimate completion date of June 4, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,610.40, is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to support federal healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,559.87, is to supply the drug Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to DLA. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,796.65, is a Firm Fixed Price Delivery Order for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The contract has a period of performance through July 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The contract, valued at $15,163.84, is a Firm Fixed Price Delivery Order with a period of performance through March 24, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is a key vendor for federal healthcare...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The contract is a firm fixed-price Delivery Order with a ceiling value of $15,057.35 and a completion date of February 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order from the Defense Logistics Agency (DLA) for Ozempic 2 mg/dose (8 mg/3 ml) 3 ml. The $7,196.87 firm fixed price contract has a completion date of May 16, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $112,614.83 firm fixed-price delivery order is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml to the DLA. The contract has an ultimate completion date of July 2, 2025 and is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FP1D9Delivery Order
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $9,392.58, is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to support federal healthcare programs. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 6/10/24 |